QFIN:NASDAQQfin Holdings, Inc. Analysis
Data as of 2026-05-29 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Qfin Holdings trades at $15.37, comfortably above its 20‑day ($13.25) and 50‑day ($13.27) SMAs but still well under the 200‑day SMA ($19.81), signaling short‑term strength within a longer‑term bearish backdrop. The stock’s PE of 2.7 is dramatically lower than the industry average of 16.5, and its price‑to‑book of 0.53 underscores a deep discount to net assets. A 10% dividend yield supported by a modest 27% payout ratio and robust operating cash flow suggests the dividend is sustainable. However, revenue has slipped 16.7% year‑over‑year, and the company carries an elevated debt‑to‑equity ratio, heightening balance‑sheet risk. Technicals are mixed: MACD is bullish, RSI sits at 64, and volume is rising, yet volatility is extreme at 84% over 30 days and beta exceeds 1, amplifying market swings. Analysts project a target price around $22, implying roughly 44% upside, while the DCF model flags a fair value far above current levels. Material news points to a Q1 earnings call highlighting continued pressure on revenue, reinforcing the need for caution despite attractive valuation metrics. Overall, the stock presents a compelling value case with strong dividend income, but faces sizable execution and regulatory headwinds in China’s credit‑services sector.
Market Outlook
Short Term
< 1 yearKey Factors
- Bullish MACD histogram and rising volume
- Significant valuation discount (PE 2.7 vs industry 16.5)
- High dividend yield with low payout ratio
Medium Term
1–3 yearsKey Factors
- Target price upside of ~44% and DCF fair value far above market
- Sustained cash generation and dividend sustainability
- Price still below long‑term SMA200 indicating room for price appreciation
Long Term
> 3 yearsKey Factors
- Revenue contraction and elevated debt‑to‑equity ratio
- High regulatory and geopolitical risk in China’s credit sector
- Strong balance‑sheet liquidity but extreme price volatility
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.